| COVID-19 |
1 |
1 |
| Cerebrospinal Fluid |
0 |
0.78 |
| Brain |
0 |
0.99 |
| Mild Cognitive Impairment |
0 |
0.43 |
| Cognitive Impairment |
0 |
0.98 |
| Acute Respiratory Distress Syndrome |
0 |
0.29 |
| Impairment |
0 |
0.21 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.21 |
| Biologic Therapy |
0 |
0.14 |
| Severe Acute Respiratory Syndrome |
0 |
0.14 |
| Vascular Endothelial Growth Factor |
0 |
0.14 |
| Adhesion |
0 |
0.07 |
| C-Reactive Protein (CRP) |
0 |
0.07 |
| California |
0 |
0.07 |
| Grant |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Interleukin |
0 |
0.07 |
| Lumbar Puncture |
0 |
0.07 |
| Lung |
0 |
0.07 |
| Memory |
0 |
0.07 |